KidneyCell
  • About
    • Technology
    • Executive Summary
    • Team
  • Studies
    • Proposed Clinical Study Protocol
    • KidneyCell II Clinical Study Results Table
    • Pilot Study
    • Clinical Trials
  • Related Articles
  • News
  • FAQ
  • Contact us
Select Page

Leonhardt’s Launchpads Announces Filing of Patent for Bioelectric Stimulation Controlled Klotho Expression – Powerful anti-aging and Regeneration Promoting Protein

by kidneycell | Jun 22, 2020 | Uncategorized

Device, programmed bioelectric signaling sequences and methods for the controlled expression of Klotho on demand via precise bioelectrical signaling sequences. Leonhardt’s Launchpads, a Los Angeles, Salt Lake City and Pittsburgh based innovation and startup...

KidneyCell Announces Launch of New Bioelectric Stimulation Study to Attempt to Reverse Kidney Failure

by kidneycell | Jun 22, 2020 | Uncategorized

The KidneyCell II Clinical Trial will feature non-invasive bioelectric stimulation controlled release of the Klotho protein known to be beneficial in kidney health  Topline Data Expected in 4Q 2020 Irvine, CA and Porto Allegre, Brazil – February 17th, 2020...

Leonhardt’s Launchpads and Leonhardt Ventures Release 2020 Annual Report ahead of Annual Shareholder Meeting April 23rd, 2020

by kidneycell | Jun 22, 2020 | Uncategorized

Download Annual Report

Leonhardt’s Launchpads Announces Issuance of New U.S. Patent for Bioelectric Plus Biologics Platform for Organ Regeneration and Healing

by kidneycell | Jun 22, 2020 | Uncategorized

Latest Patent Further Strengthens Intellectual Property Portfolio Covering Novel Platform for Precisely Controlling Regenerative Protein Expressions Including Stem Cell Homing and Differentiation Control Technology Has Key Potential Applications in Regeneration of...
Next Entries »

Recent Posts

  • Leonhardt Ventures Announces Launch of Research Program Using Patent Pending Klotho Expressing Mesenchymal Stem Cells for Multiple Applications in Combination with Bioelectric Protein Expressions
  • KidneyCell Announces Launch of New Bioelectric Stimulation Study to Attempt to Reverse Kidney Failure
  • KidneyCell Announces Issuance U.S. Patent No. 10,646,644 May 12th, 2020 with 20 Years Patent Life for Bioelectric and Biologics Based Kidney Regeneration
  • KidneyCell Files Patent for Precise Bioelectric Klotho Increase Up to 430%
  • Leonhardt’s Launchpads Medtech Accelerator Expands into Pittsburgh

Recent Comments

    Archives

    • February 2022
    • June 2020

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Facebook
    • X
    ©Copyright KidneyCell - A Leonhardt Ventures Company | Website by FizzPOP Media